Insights

Better decisions begin with deeper understanding.

Explore the expertise, insights, and perspectives from OPEN Health that help transform complexity into clarity across today’s healthcare landscape.

Showing 928–936 of 1,050 insights

A person in a lab coat and blue gloves uses a pipette to transfer pink liquid into a multi-well plate inside a laboratory setting.

Publications

Association between drug tolerability and medical resource use in prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplant

A digital illustration shows the human torso with highlighted red intestines, focussing on the digestive system within a transparent view of the abdomen.

Publications

Cost-effectiveness of 3-year vs 1-year adjuvant therapy with imatinib in patients with high risk of gastrointestinal stromal tumour recurrence in the Netherlands; a modelling study alongside the SSGXVIII/AIO trial

A human skeleton stands with one arm raised and the other extended to the side, appearing to balance or gesture against a plain light background.

Publications

Clinical, economic and humanistic burdens of skeletal-related events associated with bone metastases

A doctor examines two mammogram images displayed on monitors, focusing on breast tissue scans for signs of abnormalities.

Publications

Indirect costs associated with metastatic breast cancer

A flowchart shows study selection for a review: from 2,705 records, 9 articles were included after screening and applying eligibility criteria, with reasons for exclusions listed at each stage.

Publications

Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury

Bar chart showing mean monthly costs by loss of viral suppression: No loss (£880 drug, £283 hospital, £32 other), 1 loss (£894 drug, £384 hospital, £155 other), 2+ losses (£1,233 drug, £388 hospital, £242 other).

Publications

The prevalence of transmitted resistance to first-generation non-nucleoside reverse transcriptase inhibitors and its potential economic impact in HIV-infected patients

Flowchart of MRSA cSSTI treatment pathways showing decisions for vancomycin, daptomycin, or linezolid use, with outcomes: success, failure, or adverse events, followed by switching to second-line treatments.

Publications

Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin

Shanghai skyline at sunrise, with modern skyscrapers and the Oriental Pearl Tower by the Huangpu River, under a clear blue sky.

Publications

Rising inequalities in income and health in China: who is left behind?

Line graph comparing EQ-5D utility scores for DC impaired hands using Joint Model and Tubiana Stage Model, with both lines declining from 0.80 to 0.60 across hand categories labelled along the x-axis.

Publications

Eliciting health state utilities for Dupuytren’s contracture using a discrete choice experiment